Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GPR55‐dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans
Bo Liu, Shuang Song, Inmaculada Ruz‐Maldonado, et al.
Diabetes Obesity and Metabolism (2016) Vol. 18, Iss. 12, pp. 1263-1273
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
Mireille Alhouayek, Julien Masquelier, Giulio G. Muccioli
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 586-604
Closed Access | Times Cited: 89
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angeliki M. Angelidi, Matthew J. Belanger, Alexander Kokkinos, et al.
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 507-557
Open Access | Times Cited: 79
The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases
Antonio J. López-Gambero, Carlos Sanjuan, Pedro Jesús Serrano Castro, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 295-295
Open Access | Times Cited: 77
GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
Christopher Lipina, Sarah K. Walsh, Sharon E. Mitchell, et al.
The FASEB Journal (2018) Vol. 33, Iss. 1, pp. 1299-1312
Open Access | Times Cited: 61
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
Farjana Afrin, Mengna Chi, Andrew L. Eamens, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1033-1033
Open Access | Times Cited: 55
GPR55: a new promising target for metabolism?
Eva Tudurí, Mónica Imbernón, René Hernández-Bautista, et al.
Journal of Molecular Endocrinology (2017) Vol. 58, Iss. 3, pp. R191-R202
Open Access | Times Cited: 56
Cannabidiol oil delays pancreatic islet dysfunction in Wistar rats under hypercaloric diet
Edgardo Cortes-Justo, Rocı́o Ortiz-Butrón, Alonso Vilches‐Flores
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117993-117993
Closed Access
Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner
Anna Drzazga, Hjalti Kristinsson, Maciej Sałaga, et al.
Molecular and Cellular Endocrinology (2017) Vol. 472, pp. 117-125
Closed Access | Times Cited: 41
Islet G-protein coupled receptors: therapeutic potential for diabetes
Shanta J. Persaud
Current Opinion in Pharmacology (2017) Vol. 37, pp. 24-28
Open Access | Times Cited: 40
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Ricardo Ernesto Ramírez-Orozco, Ricardo García-Ruiz, Paula Morales, et al.
Current Neuropharmacology (2019) Vol. 17, Iss. 10, pp. 947-960
Open Access | Times Cited: 37
Lysophosphatidylinositol, especially albumin‐bound form, induces inflammatory cytokines in macrophages
Makoto Kurano, T. Kobayashi, Eri Sakai, et al.
The FASEB Journal (2021) Vol. 35, Iss. 6
Closed Access | Times Cited: 29
MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis
William J. Massey, Venkateshwari Varadharajan, Rakhee Banerjee, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 4, pp. 100349-100349
Open Access | Times Cited: 12
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor
Rangel L. Silva, Gabriela T. Silveira, Carlos W. Wanderlei, et al.
Toxicology and Applied Pharmacology (2019) Vol. 368, pp. 63-71
Closed Access | Times Cited: 32
Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract
Agnese Stanzani, Giorgia Galiazzo, Fiorella Giancola, et al.
Histochemistry and Cell Biology (2020) Vol. 153, Iss. 5, pp. 339-356
Closed Access | Times Cited: 31
Serum Lipids in Association With Type 2 Diabetes Risk and Prevalence in a Chinese Population
Yonghai Lu, Yeli Wang, Li Zou, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 103, Iss. 2, pp. 671-680
Open Access | Times Cited: 30
Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells
Chi Teng Vong, Hisa Hui Ling Tseng, Yiu Wa Kwan, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 1176-1186
Open Access | Times Cited: 28
The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling
Inmaculada Ruz‐Maldonado, Bo Liu, Patricio Atanes, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 22, pp. 4709-4723
Open Access | Times Cited: 26
Druggable Lysophospholipid Signaling Pathways
K. Yanagida, William J. Valentine
Advances in experimental medicine and biology (2020), pp. 137-176
Closed Access | Times Cited: 25
Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119
Syamsul Arifin, Silvano Paternoster, Rodrigo Carlessi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2018) Vol. 1863, Iss. 9, pp. 1132-1141
Closed Access | Times Cited: 24
Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review
Joaquim S. Pinto, Fátima Martel
Clinical Drug Investigation (2022) Vol. 42, Iss. 11, pp. 909-919
Open Access | Times Cited: 13
Exploring orphan GPCRs in neurodegenerative diseases
Devrim Öz Arslan, Melis Yavuz, Beki Kan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion
Maria Rosa Trentin Zorzenon, Amanda Nunes Santiago, Marco Mori, et al.
Chemico-Biological Interactions (2019) Vol. 312, pp. 108819-108819
Open Access | Times Cited: 22
Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors
Anna Drzazga, Marta Okulus, Magdalena Rychlicka, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1173-1173
Open Access | Times Cited: 20
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
Andrzej Wróbel, Anna Serefko, Aleksandra Szopa, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 20
CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function
Andrew McCloskey, Michael G. Miskelly, Tara Moore, et al.
Peptides (2020) Vol. 125, pp. 170251-170251
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top